Ken Griffin Bausch Health Companies Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $9.21 Million - $15.7 Million	-1,510,600 Reduced 31.19%	3,332,800 $23.2 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $21,756 - $29,708	2,800 Added 0.06%	4,843,400 $51.4 Million
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $1.8 Million - $2.27 Million	-276,100 Reduced 5.4%	4,840,600 $38.8 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $955,867 - $1.21 Million	124,300 Added 2.49%	5,116,700 $42.1 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $25.8 Million - $39.7 Million	4,510,500 Added 935.98%	4,992,400 $39.9 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $123,716 - $194,045	-19,700 Reduced 3.93%	481,900 $3.9 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $1.58 Million - $2.06 Million	-259,600 Reduced 34.1%	501,600 $3.15 Million
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $3.3 Million - $6.64 Million	-721,300 Reduced 48.65%	761,200 $5.25 Million

267

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.41B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.